Iceland vs Upper middle income: Immunization, measles second dose
Iceland
98.0%
in 2024
Upper middle income
84.9%
in 2024
Iceland rank
15th
Upper middle income rank
16th
Immunization, measles second dose over time
- Iceland
- Upper middle income
How they compare
Iceland currently reports 98.0% against 84.9% in Upper middle income, a difference of 13.1%.
That makes Iceland's figure about 1.2 times Upper middle income's.
The two have swapped places 2 times across 22 shared years of data; in 2003 it was Iceland ahead.
Iceland ranks 15th and Upper middle income ranks 16th of 178 countries.
Across the 3 decades both report, Iceland averaged higher in 2 and Upper middle income in 1.
Head to head by decade
| Decade | Iceland | Upper middle income | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.3% | 62.1% | 30.2% | Iceland |
| 2010s | 93.9% | 84.5% | 9.4% | Iceland |
| 2020s | 74.0% | 83.8% | 9.8% | Upper middle income |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Iceland or Upper middle income?
- Iceland, at 98.0% against 84.9% in Upper middle income as of 2024.
- What is the difference in immunization, measles second dose between Iceland and Upper middle income?
- 13.1%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Upper middle income?
- 22 years are reported by both, from 2003 to 2024.
- How do Iceland and Upper middle income rank globally for immunization, measles second dose?
- Iceland ranks 15th and Upper middle income ranks 16th of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.